Our 728 Patient report™

Our science and technology, logistics, and internal operations
take form 
in our proprietary 728 Patient Report™.  ​

Samples in, reports out

This unique document is organized to inform decisive decision-making, while our client portal, created to simplify access to patient reports, provide exactly the information you require, exactly when you require it.

 

Exacting quality controls combined with a proprietary algorithm ensure not only the report’s integrity but also its relevance.

For example, by including patients’ actual historical results the data reveals what a patient may conceal.

Fast, accurate and definitive

Our proprietary report supports
appropriate and timely clinical decisions

Final determination

Our determination allows clinicians to respond in the most timely manner.

Simplified summary

Our summary enables clinicians to confidently make decisions based on amounts detected at the lowest cut-off values.

Supportive notes

Our algorithms show the relationship between parent drugs and their metabolites.

Historical context

Record of patient’s behavior and test results over time promotes honest interactions.

Download a PDF version
of our 728 Patient Report™

Pumps at work-web.jpg

Do you want to try our 728 Patient Report™?

Our toxicology and clinical relations experts are available to speak with you to provide the information you need, to ensure the highest level of service.

or

About us

Our tests

Physician or practice

Patient

Insights

Acutis Diagnostics Inc. 400 Karin Lane, Hicksville, NY 11801

  • LinkedIn
  • Facebook
  • Instagram

Privacy policy
THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE.
The information contained on this website is not intended to be a substitute for or to be relied upon as, medical advice, diagnosis, or treatment. This website is for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.


© Copyright 2020 Acutis Diagnostics Inc.